Eye care sales were up by 9.8 percent to $577.8 million at Allergan in the second quarter of the year. That was just slightly behind the 10.1 percent increase in company's total sales, which rose to $1.23 billion, a 9.3 percent increase on a currency-neutral basis. Net income increased by 36 percent to $241.5 million. For the full year, the company expects total net sales to hit $4.52-4.75 billion.